Viewing Study NCT01301157


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2025-12-26 @ 8:56 PM
Study NCT ID: NCT01301157
Status: COMPLETED
Last Update Posted: 2015-11-05
First Post: 2011-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Sponsor: Maruho Co., Ltd.
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2015-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is to evaluate the efficacy and safety of M518101 and the dose relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients.
Detailed Description: This study is to evaluate the efficacy and safety of M518101 and the dose response relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients and to confirm the persistence of the effect of M518101.

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: